CENT is the first clinical trial of neurofeedback for ADHD to be held in Finland. The focus is on adults, and the project has developed its own software and completed the treatment for 25 individuals.
    In addition to testing the efficacy of neurofeedback, CENT investigates the relationship between vigilance, saliency and attention deficit, using high-resolution laboratory grade EEG.
    Gällande start-/slutdatum01/09/201131/08/2013